LG 101506: High-Purity RXR Modulator for Nuclear Receptor Signaling Research

Executive Summary: LG 101506 is a chemically defined small molecule modulator of the Retinoid X Receptor (RXR), supplied by APExBIO with a verified purity of 98.00% and a molecular weight of 420.53 g/mol. It is highly soluble in DMSO (up to 42.05 mg/ml) and ethanol (up to 21.03 mg/ml), enabling reproducible dosing in cell-based and biochemical assays (product specification). LG 101506 is intended exclusively for scientific research, with no diagnostic or therapeutic use, and is recommended for storage at -20°C to maintain stability. RXR modulators like LG 101506 are central to dissecting nuclear receptor signaling in metabolism and cancer biology, particularly in models where immune evasion and PD-L1 regulation are under study (J. Zhang et al., 2022). This article details LG 101506’s biochemical rationale, mechanism, benchmark evidence, and best-practice integration into research workflows.

Biological Rationale

The Retinoid X Receptor (RXR) is a nuclear receptor that forms heterodimers with multiple partners, including PPARs, LXRs, and RARs. RXR signaling controls transcriptional programs involved in metabolism, cellular differentiation, and immune modulation (J. Zhang et al., 2022). Dysregulation of RXR pathways is implicated in metabolic diseases, cancer, and immune escape. Small molecule RXR modulators, such as LG 101506, allow precise perturbation of these signaling cascades in vitro and in vivo. RXR’s role in regulating immune checkpoint molecules, such as PD-L1, connects its biology to anti-tumor immunity and cancer immunotherapy resistance (J. Zhang et al., 2022).

Mechanism of Action of LG 101506

LG 101506 (chemical name: (2E,4E,6Z)-7-(3,5-di-tert-butyl-2-(2,2-difluoroethoxy)phenyl)-3-methylocta-2,4,6-trienoic acid) is a synthetic ligand for RXR. Upon binding, it alters RXR conformation, modulating coactivator and corepressor recruitment to target gene promoters. This results in selective activation or repression of RXR heterodimer-regulated transcriptional programs. The compound’s high solubility in DMSO (42.05 mg/ml) and ethanol (21.03 mg/ml) allows accurate titration in both cell-free and cellular models. LG 101506 is not a pan-agonist; its modulatory profile is defined by its chemical scaffold and dose, which may show partial agonism, antagonism, or context-dependent effects depending on assay conditions and RXR partner composition (APExBIO).

Evidence & Benchmarks

• LG 101506 is supplied at ≥98.00% purity, as verified by HPLC under controlled conditions (APExBIO).
• It dissolves up to 42.05 mg/ml in DMSO and 21.03 mg/ml in ethanol at room temperature, supporting high-concentration stock solutions (APExBIO).
• RXR modulators have been shown to impact immune checkpoint regulation and anti-tumor immunity, particularly through modulation of PD-L1 expression and stability (see J. Zhang et al., 2022).
• Loss of RXR pathway regulators can alter the tumor immune microenvironment, as demonstrated in triple-negative breast cancer models where RBMS1 and PD-L1 axis are critical (J. Zhang et al., 2022).
• LG 101506’s stability is maintained when shipped on blue ice (small molecule) or dry ice (modified nucleotides), with recommended storage at -20°C to prevent degradation (APExBIO).
• In contrast to generic RXR ligands, LG 101506's characterized solubility and purity facilitate reproducibility in RXR signaling pathway research (Related Article).

This article extends prior coverage (e.g., Decoding RXR Modulation in Cellular Immunity) by detailing LG 101506’s shipping, storage, and solubility, enabling reproducible integration into metabolic and cancer immunology workflows.

Applications, Limits & Misconceptions

LG 101506 enables precise modulation of RXR activity in cell culture, biochemical, and preclinical models. It is particularly valuable in research on metabolism regulation, nuclear receptor signaling networks, and tumor immune evasion. Its use is restricted to scientific research and is not approved for diagnostic, clinical, or therapeutic applications. LG 101506 may be used to dissect RXR’s role in regulating PD-L1 stability, providing insight into mechanisms relevant to immune checkpoint blockade resistance (J. Zhang et al., 2022).

Common Pitfalls or Misconceptions

• LG 101506 is not intended for human or veterinary therapeutic use; it is for research only (APExBIO).
• Solution stability is limited; working solutions should be prepared fresh and not stored long-term to avoid compound degradation.
• Effective concentrations may vary by cell type, RXR isoform, and experimental protocol; titration is necessary.
• Not all RXR-mediated effects are recapitulated by LG 101506; context specificity and receptor crosstalk should be considered (Related Article).
• LG 101506 has not been validated in clinical diagnostic platforms; use in such settings is inappropriate.

Workflow Integration & Parameters

For optimal results, LG 101506 should be dissolved in DMSO or ethanol to prepare high-concentration stock solutions. Stocks should be aliquoted and stored at -20°C, avoiding freeze-thaw cycles. Researchers should prepare working solutions immediately before use. Standard dosing ranges from 0.1 to 10 μM in cell-based assays, with adjustment based on specific experimental endpoints (APExBIO). Shipping is performed on blue ice (small molecule form) or dry ice (nucleotide-modified form), ensuring product integrity upon arrival. For further technical guidance, see the B7414 kit product page.

This article clarifies workflow details beyond previous reviews (e.g., RXR Modulator Accelerating Nuclear Receptor Research), focusing on practical handling and solubility for reproducible results.

Conclusion & Outlook

LG 101506, from APExBIO, is a precision RXR modulator supporting advanced research in nuclear receptor signaling, metabolism regulation, and immune checkpoint biology. Its high purity, solubility, and stable formulation make it a preferred tool for dissecting RXR function in cellular and preclinical studies. Ongoing research on RXR modulators, including their role in PD-L1 regulation and tumor immunity, will further clarify the translational potential of LG 101506 in nuclear receptor-related disease models (J. Zhang et al., 2022). For researchers studying RXR in cancer biology, immune homeostasis, or metabolic regulation, LG 101506 offers reliable performance and traceable provenance.